LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $23 | $15 | $21 |
| Short-Term Investments | $5 | $28 | $0 |
| Receivables | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $0 |
| Total Curr. Assets | $29 | $46 | $21 |
| Property Plant & Equip (Net) | $4 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $5 | $0 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $34 | $46 | $21 |
| Liabilities | – | – | – |
| Payables | $2 | $1 | $0 |
| Short-Term Debt | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $1 | $0 |
| Total Curr. Liab. | $8 | $3 | $0 |
| LT Debt | $3 | $0 | $24 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $117 | $78 | $26 |
| Total NC Liab. | $120 | $78 | $50 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $4 | $0 | $0 |
| Total Liabilities | $128 | $80 | $50 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$104 | -$41 | -$35 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $10 | $6 | $6 |
| Total Equity | -$95 | -$34 | -$29 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $34 | $46 | $21 |
| Net Debt | -$19 | -$15 | $3 |